December 19, 2017 — IBA (Ion Beam Applications SA) announced that Miami Cancer Institute treated its first patients, children with cancer, on IBA’s Proteus Plus proton therapy system.
Miami Cancer Institute is equipped with a comprehensive suite of advanced radiotherapy equipment highlighted by Proteus Plus, which is equipped with a three-gantry, beam matched configuration using the latest in proton therapy including pencil beam scanning, cone beam computed tomography (CBCT) image guidance, robotic patient table and enhanced workflow. The proton therapy center will be the first in South Florida with extensive reach to the Caribbean, Latin America and beyond.
The $430 million Institute also provides a wide array of advanced radiation therapy treatment options including Gamma Knife radiosurgery, CyberKnife stereotactic radiation therapy, tomotherapy and volumetric modulated arc therapy (VMAT), brachytherapy, magnetic resonance imaging (MRI)-guided linear accelerator (linac) radiation therapy, GRID therapy and radioisotope therapy.
“This is the most cutting-edge proton therapy technology available,” said Minesh Mehta, M.D., deputy director of the Miami Cancer Institute and chief of radiation oncology. “It uses a volumetrically image-guided pencil-beam approach with on-board surface-monitoring systems with beam-gating capability, allowing us to target more complicated tumors and, for most situations, further decreases radiation exposure to normal tissues in comparison to older proton techniques. That means that there is significantly less damage to healthy tissue, a decrease in side effects and less chance of a recurrence of cancer due to radiation exposure.”
For more information: www.iba-worldwide.com
March 28, 2024 
